Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inspire Medical Systems Inc (INSP)

Inspire Medical Systems Inc (INSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Inspire Medical Systems Inc 5500 WAYZATA BLVD SUITE 1600 GOLDEN VALLEY MN 55416 USA

www.inspiresleep.com Employees: 1,246 P: 844-672-4357

Sector:

Medical

Description:

Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,769,659
Enterprise Value, $K 1,664,849
Shares Outstanding, K 28,589
Float, K 27,417
% Float 95.90%
Short Interest, K 3,869
Short Float 13.53%
Days to Cover 2.59
Short Volume Ratio 0.78
% of Insider Shareholders 4.10%
% of Institutional Shareholders 94.91%

Financials:

Annual Sales, $ 911,980 K
Annual Net Income, $ 145,420 K
Last Quarter Sales, $ 269,080 K
Last Quarter Net Income, $ 136,090 K
EBIT, $ 50,950 K
EBITDA, $ 48,640 K

Growth:

1-Year Return -66.55%
3-Year Return -77.13%
5-Year Return -74.32%
5-Year Revenue Growth 690.41%
5-Year Earnings Growth 210.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.65 on 02/11/26
Next Earnings Date 05/04/26
Earnings Per Share ttm 2.58
EPS Growth vs. Prev Qtr 334.21%
EPS Growth vs. Prev Year 43.48%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

INSP Ratios

Ratio
Price/Earnings ttm 23.41
Price/Earnings forward 31.38
Price/Earnings to Growth 2.95
Return-on-Equity % 10.96%
Return-on-Assets % 9.32%
Profit Margin % 15.95%
Debt/Equity 0.00
Price/Sales 1.89
Price/Cash Flow 21.09
Price/Book 2.25
Book Value/Share 26.88
Interest Coverage 470.29
60-Month Beta 0.74
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar